Eli Lilly and Company

Pharmareferent CMH (m/w/d) Gebiet (310902): Gelsenkirchen, Bottrop, Herten, Gladbeck, Essen-Nord

Germany

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

The ideal candidate should possess a relevant degree in pharmacy or a related scientific field, and have prior experience in pharmaceutical sales or a similar role. Strong communication and interpersonal skills are essential, along with a thorough understanding of pharmaceutical products and market dynamics.

Responsibilities

As a Pharmareferent CMH, you will be responsible for managing and supporting the commercial activities within a specific territory, including Gelsenkirchen, Bottrop, Herten, Gladbeck, and Essen-Nord. This role involves building and maintaining relationships with healthcare professionals, providing product information and training, and achieving sales targets. You will also contribute to market analysis and strategic planning, and collaborate with cross-functional teams to ensure successful product launches and market penetration.

Skills

Teamwork
Independent working
Flexibility
Idea contribution
Project management
Professional development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI